Candriam S.C.A. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$83.14 - $145.99 $12 Million - $21.1 Million	144,428 New	144,428 $21 Million
Q4 2021 Feb 10, 2022	SELL	$99.73 - $148.48 $4.69 Million - $6.98 Million	-47,005 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$65.78 - $105.02 $135,638 - $216,551	-2,062 Reduced 4.2%	47,005 $4.56 Million
Q4 2020 Jan 22, 2021	SELL	$65.07 - $98.24 $7.02 Million - $10.6 Million	-107,820 Reduced 68.72%	49,067 $4.21 Million
Q3 2020 Oct 19, 2020	SELL	$59.04 - $77.95 $939,444 - $1.24 Million	-15,912 Reduced 9.21%	156,887 $10.2 Million
Q2 2020 Jul 23, 2020	SELL	$29.01 - $74.23 $464,160 - $1.19 Million	-16,000 Reduced 8.47%	172,799 $12.6 Million
Q4 2019 Jan 21, 2020	SELL	$40.86 - $57.65 $9.44 Million - $13.3 Million	-231,000 Reduced 55.03%	188,799 $10,000
Q3 2019 Oct 21, 2019	SELL	$37.38 - $49.47 $1.42 Million - $1.88 Million	-38,000 Reduced 8.3%	419,799 $18,000
Q2 2019 Aug 01, 2019	BUY	$39.79 - $67.01 $596,850 - $1.01 Million	15,000 Added 3.39%	457,799 $20 Million
Q1 2019 May 02, 2019	SELL	$34.52 - $53.29 $3.62 Million - $5.6 Million	-105,000 Reduced 19.17%	442,799 $22.8 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $3.88 Million - $5.6 Million	130,500 Added 31.27%	547,799 $20.3 Million
Q3 2018 Nov 07, 2018	BUY	$32.79 - $43.0 $6.89 Million - $9.04 Million	210,200 Added 101.5%	417,299 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $2.41 Million - $4.32 Million	102,099 Added 97.24%	207,099 $8.19 Million
Q1 2018 May 09, 2018	BUY	$22.49 - $34.56 $562,250 - $864,000	25,000 Added 31.25%	105,000 $2.71 Million
Q4 2017 Feb 07, 2018	BUY	$20.44 - $35.56 $1.64 Million - $2.84 Million	80,000	80,000 $2.16 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account